Purpose: Hyperpolarization of carbon-13 ( 13 C) nuclei by dissolution dynamic nuclear polarization increases signal-to-noise ratio (SNR) by >10,000-fold for metabolic imaging, but care must be taken when transferring hyperpolarized (HP) samples from polarizer to MR scanner. Some 13 C substrates relax rapidly in low ambient magnetic fields. A handheld electromagnet carrier was designed and constructed to preserve polarization by maintaining a sufficient field during sample transfer. Methods: The device was constructed with a solenoidal electromagnet, powered by a nonmagnetic battery, holding the HP sample during transfer. A specially designed switch automated deactivation of the field once transfer was complete. Phantom and rat experiments were performed to compare MR signal enhancement with or without the device for HP [
INTRODUCTION
Hyperpolarized carbon-13 (HP 13 C) MRI with dissolution dynamic nuclear polarization (DNP) (1) has recently been shown to provide biologic information on previously inaccessible aspects of metabolic processes by detecting endogenous, nontoxic 13 C-labeled probes to monitor enzymatic conversions through key biochemical pathways (2) (3) (4) . Because both spatial and chemical information are encoded, this new molecular imaging modality allows simultaneous detection of multiple biologic compounds and metabolic products with sensitivity enhancements of >10,000-fold (1). The recently completed phase 1 clinical trial conducted at the University of California, San Francisco, demonstrated the safety and feasibility of HP 13 C-pyruvate MRI in prostate cancer patients without any dose-limiting or other notable toxicities (5) .
Some HP 13 C substrates can lose polarization extremely quickly in low magnetic field when they are transferred between the polarizer and the MR scanner, reducing the SNR. For example, scalar coupling between fast-relaxing quadrupolar 14 N and 13 C results in rapid loss of polarization of [ 13 C]urea (6) . Although most in vivo HP 13 C MRI studies have focused on probing metabolism using metabolically active substrates (7) , several studies have shown that metabolically inactive agents such as [ 13 C]urea can be applied to angiography or perfusion imaging (8, 9) . HP [ 13 C]urea for perfusion MRI has advantages over conventional gadolinium-containing (paramagnetic) contrast agents, including direct proportionality of signal to concentration, inherently high contrast-to-noise ratio due to the absence of background signal, and an excellent safety profile potentially benefitting studies in patients who are currently excluded from contrast imaging studies. In addition, [ 13 C]urea can be copolarized with [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate for combined perfusion and metabolic imaging (10, 11) . Urea is a safe, endogenous compound with normally high concentrations in vivo (typically 1-10 mM, and much higher in the renal medullary interstitium), low toxicity, and neutral pH, as well as the key MR properties of long T 1 relaxation time and high polarization by DNP. Recent studies have also demonstrated the ability of HP [
13 C]urea to identify changes in urea transport and concentration in the kidney (12) .
In previous studies, this loss of polarization of [ 13 C NMR resonance peak into a triplet, thus lowering the signal amplitude and potentially confounding quantitation. The permanent magnet method raises safety concerns, because the magnet could cause harm by flying into the scanner. In addition, permanent magnets provide nonuniform fields and are impractical for large samples. To address these limitations, we constructed and tested a new electromagnet carrier device to provide a suitable and relatively uniform magnetic field for the safe transfer of HP samples for 13 C MR studies.
THEORY
Spin-lattice relaxation depends on several independent mechanisms, including interactions with paramagnetic centers and scalar coupling between fast-relaxing quadrupolar nuclei, which cause faster relaxation when the magnetic field decreases. Quadrupolar nuclei with spin >1/2 (eg, 14 N) have very short T 1 values. The scalar coupling of 13 C to 14 N provides a relaxation mechanism for 13 C as 14 N is undergoing very rapid T 1 relaxation. The scalar coupling relaxation rate can be calculated by
where R sc is the scalar coupling relaxation rate, J is the scalar coupling constant in Hertz, I is the spin quantum number of the coupled nucleus (I 14N ¼ 1), T 1 is the spinlattice relaxation time of the quadrupolar nucleus ( 14 N), and Dv ¼ v 13c À v 14N is the difference in Larmor frequencies of coupled nuclei 13 C and 14 N. For this mechanism to be effective, the Larmor frequencies of these two nuclei must be very close. This condition is met at low magnetic fields (eg, during HP sample transfer), although it may also occur at high fields (eg, for (14) . One approach to reduce the scalar coupling relaxation mechanism is to increase the external magnetic field.
METHODS

Simulation and Background Field Measurements
The ambient magnetic field through which the HP samples were transferred was measured with a three-axis Hall effect magnetometer (THM 7025; Metrolab Technology SA, Geneva, Switzerland), as shown in Figure 1A . R sc was estimated as a function of magnetic field based on Equation 1 according to the parameters described in Chiavazza et al. (6) , including T 1 ¼ 1.0 6 0.1 ms and J ¼ 14.5 6 0.1 Hz (Fig. 1B) . Assuming a piece-wise constant relaxation rate along the path and constant transfer velocity over a 6s transfer, the signal decay curve can be estimated along this path (Fig. 1C) .
By adding a magnetic field offset of 50 G (in the vertical direction) in simulation, this scalar coupling relaxation mechanism can be significantly reduced as shown in Figure 1B , resulting in a 1.83-fold signal improvement at the end of the path as shown in Fig. 1C . This field strength specification was used for the design of this device to provide an adequate magnetic field to maintain a long T 1 for HP samples during transfer.
Hardware
The electromagnet carrier device was designed to provide a suitable magnetic field for the safe transfer of HP samples. The key part of the device is a solenoid with a current of 0.5 A powered by a nonmagnetic battery to generate a relatively uniform magnetic field of >50 G over a 6-cm longitudinal section. The size of the solenoid was customized for the specific 3-mL and 5-mL syringes (BD, Franklin Lakes, New Jersey, USA) commonly used for preclinical HP 13 C studies. The inner diameter and the length were designed to be 1.65 cm and 7.9 cm, respectively. The gauge of the wire (22 AWG) and number of layers (six) were chosen based on the desired field of 50 G, resulting in a total of 727 turns.
The circuit is shown in Figure 2A . A single-cell (3.7 V), 500-mAH lithium-ion polymer battery (E-flite; Horizon Hobby, Champaign, Illinois, USA) composed of nonmagnetic materials powered the magnetic field. The device can be safely carried into the 3 T MRI scanner room and turned off there. The current was activated by depressing the default-open, push-button momentary switch. When the button was released, the current was turned off automatically. The design of the switch ensures that the device can be safely operated in the scanner room, covering the entire sample transfer path and thus minimizing the loss of polarization. An LED was installed to indicate when the device was activated. The battery can provide stable current for at least 1 hour of continuous use. The sample transfer duration is <10 s, so one battery charge can last for hundreds of hyperpolarization experiments. The device (Fig. 2C ) was constructed using a combination of custom three-dimensional (3D)-printed parts and commercially available parts meeting the design criteria for performance, nonmagnetic materials, and durability. The housing was built with strength to withstand drops to the floor, and the shape was designed for ease of carrying and standing upright. The switch was triggermounted to enable easy depression, holding and releasing of the button. The battery was attached on the surface of the device in a manner allowing easy replacement or charging. The inner diameter of the solenoid-encompassed sample chamber closely fits the syringes, which are quickly guided through a conical opening on top of the coil, as shown in Figure 2B .
Magnetic Field Measurements
The strength, stability, and uniformity of the device magnetic field were simulated and measured. The magnetic field strength along the central axis was first simulated based on the Biot-Savart Law. Assuming the magnetic field in the solenoid is uniform, the field strength along the central axis approximates the field inside the solenoid. The same magnetometer described above was used to measure the field inside the solenoid. The solenoid for the actual device had a smaller inner diameter, which was customized for the sample size. This smaller size was too narrow for the probe of the magnetometer. Therefore, a prototype solenoid of larger size was constructed to test the accuracy of the field simulation in comparison with the measured results.
HP MR Phantom Experiments
Experiments were performed to test the effect of the device on HP [ 13 C]pyruvate. Dissolution DNP was performed with a HyperSense polarizer (Oxford Instruments, Oxford, UK) operating at 1.3 K and 3.35 T, using previously described methods, generating 4.5 mL of the 100 mM HP solution (11) . MR experiments were performed on a 3 T clinical MRI scanner (GE Healthcare, Waukesha, Wisconsin, USA) with a broadband radiofrequency amplifier. Custom built, dual-tuned mouse birdcage coils (l ¼ 8 cm, d ¼ 5 cm) were used for radiofrequency transmission and signal reception. The radiofrequency transmit gain was calibrated with a 13 C-enriched urea phantom with similar size and similar location as the HP phantom.
After dissolution, the HP sample was divided into two equally apportioned syringes, and both were carried to the scanner at the same speed along the same path. One was transferred in the ambient field, while the other was transferred with this device. The device was turned on during DNP dissolution and kept activated throughout the transfer from DNP polarizer to MR scanner. It was deactivated approximately 2 m away from the center of the MR scanner, where the fringe field is already sufficiently large. The device was held vertically during transfer such that the magnetic field from this device was added to the fringe field instead of potentially cancelling each other. The sample transfer took approximately 6 s.
The solutions were then injected into two fixed syringe reservoirs already lying inside the coil, oriented along the longitudinal direction. The signal of these two samples was then acquired together with one pulse sequence and approximately the same local B 0 and B 1 fields. In this manner, the differences in signal between the samples transferred with and without the device were calculated from the same experiment, while controlling for any variations in initial polarization, total amount of sample, and transfer duration. Another control group experiment was performed with the same imaging methods, but both samples were transferred without the device. The ureaonly experiment and control group experiment were each repeated four times, and the copolarization experiment was repeated five times.
For the urea-only tests, the axial images were acquired with single-shot echo planar imaging (EPI) readout, with no localization along the longitudinal direction, using the following parameters: flip angle ¼ 90 ; echo time (TE) ¼ 100 ms; repetition time (TR) ¼ 250 ms; matrix size ¼ 20 Â 20; field of view ¼ 10 Â 10 cm. For urea and pyruvate copolarization tests, a dynamic onedimensional MR spectroscopic imaging sequence was used with hard pulse excitation (0.5 ms duration), double spin echo refocusing, and symmetric EPI readout (15) . Spatial encoding was only applied along the x direction (right/left) with projections along the y and z directions. Localization along this direction enabled separation of the samples transferred with and without the device. The readout gradient duration was 100 ms, giving a spectral resolution of 10 Hz, with a spectral bandwidth of 543 Hz to include the resonances of both pyruvate and urea. For image reconstruction, the even and odd EPI lobe data were combined by the sum-ofsquares method. The data were acquired using the following parameters: flip angle ¼ 10 ; TE ¼ 140 ms; TR ¼ 2 s. Although the amounts of HP material in each syringe were approximately equal, the signal at thermal equilibrium was also measured to compensate for any potential residual differences in the amount of HP sample in each syringe.
HP MR In Vivo Experiments
HP [
13 C]urea in vivo rat experiments were performed using a balanced steady state free precession (bSSFP) sequence (13) to acquire a coronal image (projection along the anterior-posterior direction) following a protocol approved by our Institutional Animal Care and Use Committee. The experiments were repeated twice on the same animal, one with HP sample transferred in ambient field, the other transferred with this device, while keeping all the other parameters the same. [ 
RESULTS
Magnetic Field Tests
The simulated and measured magnetic field distributions within the solenoid are shown in Figure 3 . Figure 3A corresponds to the larger prototype solenoid, while Figure 3B corresponds to the actual solenoid used in this device. The measured results were close to the simulated results, but slightly higher in the center, as shown in Figure 3A . Using the same simulation method, we calculated the magnetic field of the device to be > 50 G over a 6-cm central section, as shown in Figure 3B . Even though the magnetic field drops quickly at both ends, the field is relatively uniform in the 3-cm central section where HP media is usually placed. When holding the switch and keeping the electric current on for about 30 s (the sample transfer usually takes <10 s), the measured magnetic field remained constant, thereby demonstrating the stability of the device.
HP MR Tests
In the HP [
13 C]urea phantom experiments, the [ 13 C]urea signal in both syringes is shown in one axial image (Fig. 4A) . The SNR increase achieved by using this device was demonstrated by the ratio of image intensity. The results showed a significantly (P ¼ 0.012) higher (1.9 6 0.2) [
13 C]urea signal using the device. The result of the control group demonstrated a small effect between syringe locations (þ4%). However, this effect was much smaller than the experimental signal ratio ($1.9) and therefore does not alter the conclusion that SNR increased by about two-fold. Furthermore, this small effect in the control group failed to reach statistical significance (P ¼ 0.098).
For the HP copolarization phantom experiments, spectroscopic imaging was acquired to distinguish the different compounds based on frequency, and the different samples transferred with and without the device based on spatial location. The spectra were analyzed for each resonance and each transfer approach (Fig. 4B) . The data showed a significantly (P ¼ 0.002) higher (1.9 6 0.3) ]urea experiments, HP urea and pyruvate copolarization experiments, and one in vivo experiment. The observed 1.8-to 1.9-fold SNR improvement from experiments is close to the expected 1.83-fold increase predicted by simulation, which indicates that the hypothesis of fast signal decay due to scalar coupling relaxation is correct and that the model we use (Eq. 1) is accurate. Therefore, this model can be used for further study with other HP molecules. The SNR improvement may be even more significant in cases where the ambient field along transfer path is lower than in our facility.
Although [1- 13 C]pyruvate is not affected by scalar coupling relaxation, other relaxation mechanisms could affect it at low fields, such as relaxation via paramagnetic centers (radical and gadolinium in solution). However, in our copolarization experiments, the [1-
13 C]pyruvate signal was not significantly different with or without the device. Theoretically, the effect of relaxation via paramagnetic centers is small due to very low concentration of radical or gadolinium in the liquid state (16, 17) . Furthermore, this possible mechanism would likely have a small effect considering the transfer time is just 6 s, as a small fraction of expected T1 value (18) . However, use of this device would prevent pyruvate relaxation effects that could occur at very low fields at some locations.
While the initial testing was focused on HP [ 13 C]urea and [1-
13 C]pyruvate, it could also benefit other compounds. For example, HP [5- 13 C]glutamine is being developed as a noninvasive imaging marker for   FIG. 4 . Example of experimental comparisons between two HP samples scanned in one acquisition. One sample was transported with this device (with carrier), the other was transported in an ambient field (without carrier). The just urea experiment was performed using axial 13 C MRI (A), while the copolarization of urea and pyruvate MR spectroscopic imaging experiment resulted in two spectral peaks corresponding to the two HP compounds acquired from the samples transported with (solid red line) and without (dotted blue line) the carrier device (B). For copolarization results, the left peak corresponds to pyruvate and the right peak corresponds to urea. The center frequency was set close to the urea frequency. Images B and C were acquired with the same imaging parameters and experimental setup and differed only in the transfer method. Images B and C are displayed with the same window. The SNR (measured at right kidney center) in image B was 1.8 times higher using the device than without (image C).
glutaminolysis, allowing improved diagnosis and monitoring of glutamine-dependent tumors (19) (20) (21) . Similar to urea, this substrate is also affected by coupling between 13 C and 14 N.
CONCLUSION
An electromagnet carrier device was designed and built to supply a suitable and safe magnetic field (>50 G) to preserve polarization during HP sample transfer, especially for compounds with scalar coupling between fast-relaxing quadrupolar 14 N and 13 
